Invasive pulmonary aspergillosis is an increasingly recognised condition, occurring almost exclusively in severely immunocompromised patients.' Fewer than 30 cases of invasive pulmonary aspergillosis have been described in apparently immunocompetent hosts; most of these patients had one or more possible risk factors, such as fibrotic lung disease,2 use of corticosteroids,3 recent influenza or psittacosis infection,4 and possibly alcoholism. The prognosis of invasive pulmonary aspergillosis is dismal in both immunosuppressed and immunocompetent patients. We report a non-immunosuppressed patient who was apparently cured after systemic treatment with amphotericin and flucytosine, together with inhalations of aerosolised amphotericin.
Invasive pulmonary aspergillosis is an increasingly recognised condition, occurring almost exclusively in severely immunocompromised patients. ' Fewer than 30 cases of invasive pulmonary aspergillosis have been described in apparently immunocompetent hosts; most of these patients had one or more possible risk factors, such as fibrotic lung disease,2 use of corticosteroids,3 recent influenza or psittacosis infection,4 and possibly alcoholism. The prognosis of invasive pulmonary aspergillosis is dismal in both immunosuppressed and immunocompetent patients. We report a non-immunosuppressed patient who was apparently cured after systemic treatment with amphotericin and flucytosine, together with inhalations of aerosolised amphotericin. Several days before admission he had developed a nonproductive cough with dyspnoea and wheezing. Because of concomitant alcohol intoxication his memory was only fragmentary. On admission he was cyanosed and obtunded with pyrexia of 40 4°C. The chest radiograph showed an opacity in the left lower lobe. The white blood count was 9-3 x 109/l with a normal differential count. Microscopic examination of a sputum sample showed no pathogens and treatment was started with cefuroxime, corticosteroids, and theophylline. During the next few days the patient's condition rapidly improved, the fever abated, and the chest radiograph showed progressive clearing of the infiltrate.
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On bronchoscopic examination no abnormalities were noted and cultures were negative. Cytological examination of the brushings obtained at bronchoscopy showed branching septate hyphae consistent with A fiumigatus, but these findings were considered of no clinical significance.
On the 19th hospital day the fever recurred and the patient felt weak. Tobramycin was added to the regimen with no improvement. Therapeutic trials with erythromycin and co-trimoxazole were also ineffective. The patient's condition gradually deteriorated and the chest radiograph showed patchy infiltration in both lung fields, with a large cavitating mass in the left upper lobe (fig) . Tomography showed several cavities, some with air-fluid levels. All antibiotics were discontinued and on the 36th hospital day a percutaneous lung biopsy specimen was obtained. Pathological examination showed necrotic lung parenchyma with a dense polymorph infiltration containing many eosinophils. Cultures yielded abundant growth of A fumigatus; no other microorganisms were found.
On the 41st hospital day antimycotic treatment was started, consisting of oral flucytosine 150 mg/kg daily and amphotericin increasing to 50 mg intravenously per day. Amphotericin was also given by inhalation together with 3 ml of 5% dextrose in a model 1720 "up draft" nebuliser (Hudson, Temecula, California). The aerosol was inhaled four times daily. The starting dose was 5 mg/day and was doubled daily until a dose of 100 mg/day was reached.
The patient remained afebrile and the chest radiograph slowly improved, with a residual cavity in the left upper lobe. Because 
